These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 155781

  • 1. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
    Müller EE, Parati EA, Panerai AE, Cocchi D, Caraceni T.
    Neuroendocrinology; 1979; 28(5):313-9. PubMed ID: 155781
    [Abstract] [Full Text] [Related]

  • 2. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
    Caraceni T, Panerai AE, Paratl EA, Cocchi D, Müller EE.
    J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F, Cesselin F, Bression D, Zygelman N, Brandi AM, Nousbaum A, Mauborgne A.
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
    Sakuma H, Takase S, Mizuno Y, Teramura K, Hanew K.
    Tohoku J Exp Med; 1988 Nov; 156(3):291-8. PubMed ID: 3252557
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K, Sasaki A, Sato S, Goh M, Yoshinaga K.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
    Lorenzi M, Tsalikian E, Bohannon NV, Gerich JE, Karam JH, Forsham PH.
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1154-8. PubMed ID: 591612
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
    Chalmers RJ, Johnson RH, Keogh HJ, Nanda RN.
    J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
    Podolsky S, Leopold NA.
    J Clin Endocrinol Metab; 1974 Jul; 39(1):36-9. PubMed ID: 4276011
    [No Abstract] [Full Text] [Related]

  • 12. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J, Koulu M, Scheinin M, Syvälahti E.
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [Abstract] [Full Text] [Related]

  • 13. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R, Tamminga CA, Denaro A, Ruggeri S, Chase TN.
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [Abstract] [Full Text] [Related]

  • 14. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
    Corsini GU, Onali P, Masala C, Cianchetti C, Mangoni A, Gessa G.
    Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
    [Abstract] [Full Text] [Related]

  • 15. Neuroendocrinologic findings in patients with untreated Huntington's chorea.
    Caraceni TA, Parati EA, Giovannini PM, Grassi MP, Scigliano G, Carella F, Müller EE.
    Arch Neurol; 1984 May; 41(5):516-20. PubMed ID: 6232913
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA, Hassing JM.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man.
    Vance ML, Kaiser DL, Frohman LA, Rivier J, Vale WW, Thorner MO.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1136-41. PubMed ID: 3553220
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effect of apomorphine and L-DOPA on serum growth hormone levels in normal men.
    Lal S, Martin JB, De la Vega CE, Friesen HG.
    Clin Endocrinol (Oxf); 1975 May; 4(3):277-85. PubMed ID: 1149303
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.